Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1973 1
1974 4
1975 1
1976 1
1977 1
1979 2
1983 2
1984 3
1985 3
1986 2
1990 2
1991 3
1992 2
1993 2
1994 4
1996 1
1997 3
1998 1
1999 2
2000 7
2001 2
2002 7
2003 12
2004 14
2005 8
2006 14
2007 12
2008 13
2009 15
2010 15
2011 22
2012 22
2013 17
2014 23
2015 25
2016 23
2017 27
2018 29
2019 21
2020 17
2021 15
2022 14
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Alcohol and hepatocellular carcinoma.
Matsushita H, Takaki A. Matsushita H, et al. Among authors: takaki a. BMJ Open Gastroenterol. 2019 Apr 3;6(1):e000260. doi: 10.1136/bmjgast-2018-000260. eCollection 2019. BMJ Open Gastroenterol. 2019. PMID: 31139422 Free PMC article. Review.
Clinical practice guidelines for autoimmune hepatitis.
Ohira H, Takahashi A, Zeniya M, Abe M, Arinaga-Hino T, Joshita S, Takaki A, Nakamoto N, Kang JH, Suzuki Y, Sogo T, Inui A, Koike K, Harada K, Nakamoto Y, Kondo Y, Genda T, Tsuneyama K, Matsui T, Tanaka A. Ohira H, et al. Among authors: takaki a. Hepatol Res. 2022 Jul;52(7):571-585. doi: 10.1111/hepr.13776. Epub 2022 May 25. Hepatol Res. 2022. PMID: 35533021 No abstract available.
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab.
Takeuchi Y, Nouso K, Fujioka SI, Kariyama K, Kobashi H, Uematsu S, Moriya A, Hagihara H, Takabatake H, Nakamura S, Yabushita K, Kikuchi T, Oyama A, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A. Takeuchi Y, et al. Among authors: takaki a. Cancer Med. 2023 Sep;12(17):17559-17568. doi: 10.1002/cam4.6369. Epub 2023 Aug 3. Cancer Med. 2023. PMID: 37537956 Free PMC article.
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
Gatselis NK, Zachou K, Loza AJM, Cançado ELR, Arinaga-Hino T, Muratori P, Efe C, Floreani A, Invernizzi P, Takahashi A, Takaki A, Beretta-Piccoli BT, van Hoek B, Lytvyak E, Guedes LV, Purnak T, Cazzagon N, Lygoura V, Arvaniti P, Rigopoulou EI, Muratori L, Dalekos GN; International Autoimmune Hepatitis Group. Gatselis NK, et al. Among authors: takaki a. Eur J Intern Med. 2023 Oct;116:43-50. doi: 10.1016/j.ejim.2023.06.001. Epub 2023 Jun 10. Eur J Intern Med. 2023. PMID: 37302951
A case of Mycobacterium tuberculosis laboratory cross-contamination.
Takeda K, Murase Y, Kawashima M, Suzukawa M, Suzuki J, Yamane A, Igarashi Y, Chikamatsu K, Morishige Y, Aono A, Yamada H, Takaki A, Tamura A, Nagai H, Matsui H, Tohma S, Mitarai S. Takeda K, et al. Among authors: takaki a. J Infect Chemother. 2019 Aug;25(8):610-614. doi: 10.1016/j.jiac.2019.03.012. Epub 2019 Apr 11. J Infect Chemother. 2019. PMID: 30982725
376 results